Cambridge, MA, United States of America

Germain Margall Ducos

This inventor holds 1 USPTO granted patent. Top assignee: Hifibio (Hk) Limited. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Germain Margall Ducos. Retrieved from https://idiyas.com/inventor/germain-margall-ducos-bpfg9btk

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Germain Margall Ducos: Innovator in Antibody Development

Introduction

Germain Margall Ducos is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. His innovative work has led to the filing of a patent that showcases his expertise and dedication to advancing medical science.

Latest Patents

Ducos holds a patent for an "ANTI-GALECTIN-9 ANTIBODY AND USES THEREOF." This patent represents a crucial advancement in the understanding and application of antibodies in therapeutic contexts. With 1 patent to his name, Ducos is making strides in the biotechnology sector.

Career Highlights

Currently, Ducos is associated with Hifibio (HK) Limited, where he continues to push the boundaries of antibody research. His role at the company allows him to collaborate with other talented professionals in the field, contributing to innovative solutions in healthcare.

Collaborations

Ducos has worked alongside notable colleagues such as Nicola Arturo Aldo Beltraminelli and Francisco Adrian. These collaborations enhance the research environment and foster the development of groundbreaking technologies.

Conclusion

Germain Margall Ducos is a prominent figure in the biotechnology industry, with a focus on antibody development. His contributions are paving the way for future innovations in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…